Daewon Pharmaceutical Co Ltd
KRX:003220
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| KR |
|
Daewon Pharmaceutical Co Ltd
KRX:003220
|
244.1B KRW |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.1B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
283.4B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
296.9B USD |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
231.1B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.8B GBP |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124B USD |
Loading...
|
Market Distribution
| Min | -168 471.3% |
| 30th Percentile | -2.9% |
| Median | 1.9% |
| 70th Percentile | 5.8% |
| Max | 21 012.5% |
Other Profitability Ratios
Daewon Pharmaceutical Co Ltd
Glance View
Daewon Pharmaceutical Co., Ltd. engages in the production and sale of pharmaceutical products. The company is headquartered in Seoul, Seoul. The Company’s products include antipyretics, analgesics, anti-inflammatory drugs, respiratory drugs, gastrointestinal drugs, antimicrobial drugs, cardiovascular drugs, metabolic drugs, psychoneurotic drugs, neuromuscular drugs, endocrine drugs and others. The firm also produces multivitamins and health foods. The firm distributes its products within domestic market and overseas markets, including Vietnam, Myanmar, Southeast Asia, the Middle East and others.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Daewon Pharmaceutical Co Ltd is -2.7%, which is below its 3-year median of 3.1%.
Over the last 3 years, Daewon Pharmaceutical Co Ltd’s Net Margin has decreased from 7.6% to -2.7%. During this period, it reached a low of -2.7% on Sep 30, 2025 and a high of 7.6% on Sep 30, 2022.
